High-titer glucagon antibodies in a hypoglycemic child on glucagon therapy.
High-titer (1:30,000) antiglucagon antibodies were detected in a 14-month-old patient with nesidioblastosis who had been treated by intramuscular long-acting glucagon since age 5 months. In this patient no correct equilibrium of blood glucose level could be obtained without maintaining glucagon treatment, even after subtotal pancreatectomy. Antiglucagon antibodies titer remained stable at age 18 months.